XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
ANL Adlai Nortye
- 2.250
- -0.050-2.17%
Close Feb 14 16:00 ET
- 2.250
- 0.0000.00%
Post 20:01 ET
83.03MMarket Cap-1.54P/E (TTM)
2.420High2.140Low10.82KVolume2.140Open2.300Pre Close24.82KTurnover0.06%Turnover RatioLossP/E (Static)36.90MShares17.48052wk High1.56P/B39.30MFloat Cap1.85052wk Low--Dividend TTM17.47MShs Float19.300Historical High--Div YieldTTM12.17%Amplitude1.850Historical Low2.293Avg Price1Lot Size
Adlai Nortye Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 5M | 0 | 0 | 0 | 0 | 0 | 45.73M |
| Operating revenue | --5M | --0 | --0 | --0 | --0 | --0 | --45.73M |
| Cost of revenue | |||||||
| Gross profit | |||||||
| Operating expense | 7.85%72.55M | -3.79%16.86M | 35.20%15.26M | 23.72%67.27M | 17.53M | 11.29M | 54.37M |
| Selling and administrative expenses | 17.26%15.29M | -32.19%3.08M | -13.83%2.15M | 4.73%13.04M | --4.55M | --2.49M | --12.45M |
| -General and administrative expense | 17.26%15.29M | -32.19%3.08M | -13.83%2.15M | 4.73%13.04M | --4.55M | --2.49M | --12.45M |
| Research and development costs | 6.72%58.15M | 7.08%13.94M | 49.54%13.31M | 29.41%54.49M | --13.01M | --8.9M | --42.11M |
| Other operating expenses | -243.63%-890K | -369.70%-155K | -86.54%-194K | -41.53%-259K | ---33K | ---104K | ---183K |
| Operating profit | -0.42%-67.55M | 3.79%-16.86M | -35.20%-15.26M | -678.05%-67.27M | -17.53M | -11.29M | -8.65M |
| Net non-operating interest income expense | -82.68%-791K | -55.24%-163K | 49.04%-80K | 67.61%-433K | -105K | -157K | -1.34M |
| Non-operating interest expense | 82.68%791K | 55.24%163K | -49.04%80K | -25.22%433K | --105K | --157K | --579K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | --758K |
| Other net income (expense) | -502.63%-35.89M | -427.97%-46.37M | -14.81%322K | 119.09%8.91M | 14.14M | 378K | -46.7M |
| Gain on sale of security | -94.00%62K | -100.23%-1K | -77.70%64K | 1,336.11%1.03M | --438K | --287K | --72K |
| Other non- operating income (expenses) | -556.25%-35.95M | -438.45%-46.37M | 183.52%258K | 116.85%7.88M | --13.7M | --91K | ---46.77M |
| Income before tax | -77.29%-104.23M | -1,715.49%-63.4M | -35.72%-15.02M | -3.73%-58.79M | -3.49M | -11.07M | -56.68M |
| Income tax | 643K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -78.38%-104.87M | -1,715.49%-63.4M | -35.72%-15.02M | -3.73%-58.79M | -3.49M | -11.07M | -56.68M |
| Net income continuous Operations | -78.38%-104.87M | -1,715.49%-63.4M | -35.72%-15.02M | -3.73%-58.79M | ---3.49M | ---11.07M | ---56.68M |
| Minority interest income | |||||||
| Net income attributable to the parent company | -78.38%-104.87M | -1,715.49%-63.4M | -35.72%-15.02M | -3.73%-58.79M | -3.49M | -11.07M | -56.68M |
| Preferred stock dividends | |||||||
| Other preferred stock dividends | |||||||
| Net income attributable to common stockholders | -78.38%-104.87M | -1,715.49%-63.4M | -35.72%-15.02M | -3.73%-58.79M | -3.49M | -11.07M | -56.68M |
| Basic earnings per share | -355.68%-7.26 | -1,651.89%-1.7181 | -35.72%-0.4024 | -3.73%-1.5932 | -0.0981 | -0.2965 | -1.536 |
| Diluted earnings per share | -355.68%-7.26 | -1,651.89%-1.7181 | -35.72%-0.4024 | -3.73%-1.5932 | -0.0981 | -0.2965 | -1.536 |
| Dividend per share | |||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Trending Stocks
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?